Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cancer Treatment Reviews|June 10, 2020
Cancer and COVID-19: Unmasking their tiesA Addeo, A Friedlaender
International Journal of Surgery Case Reports|June 19, 2013
Von Hippel-Lindau and myotonic dystrophy of Steinert along with pancreatic neuroendocrine tumor and renal clear cell carcinomal neoplasm: Case report and review of the literatureA Addeo, R Bini, T Viora, et al.
Annals of the Royal College of Surgeons of England|July 4, 2014
The role of surgery in a case of diffuse mucormycosis with haematemesis and gastric necrosisR Bini, A Addeo, L Maganuco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Phase II study of cisplatin, gemcitabine and 5-fluorouracil in advanced pancreatic cancerA Novarino, I Chiappino, G F Bertelli, et al.
Lung Cancer (Amsterdam, Netherlands)|January 18, 2025
Targeted therapy for older patients with an oncogene driven non-small cell lung cancer: Recommendations from a SIOG expert groupL Decoster, D R Camidge, J A Fletcher, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 2, 2020
Neutrophil-to-lymphocyte ratio and lactate dehydrogenase as biomarkers for urothelial cancer treated with immunotherapyG L Banna, R Di Quattro, L Malatino, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 19, 2018
Metronomic oral vinorelbine for the treatment of advanced non-small cell lung cancer: a multicenter international retrospective analysisA Camerini, G L Banna, S Cinieri, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 17, 2021
Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysisG Metro, A Gili, D Signorelli, et al.
ESMO Open|November 19, 2025
The risk of lung cancer from vaping or e-cigarette usage: a systematic reviewS Mohapatra, A Tiwari, A Kandala, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2023
Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort studyA Schuler, J Huser, S Schmid, et al.
Pageof 2